Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study
-
Published:2024-03
Issue:
Volume:22
Page:100361
-
ISSN:2772-3682
-
Container-title:The Lancet Regional Health - Southeast Asia
-
language:en
-
Short-container-title:The Lancet Regional Health - Southeast Asia
Author:
Asokan Mangaiarkarasi S.ORCID, Joan Roshni Florina, Babji Sudhir, Dayma GirishORCID, Nadukkandy Prajitha, Subrahmanyam Vinutha, Pandey Archana, Malagi Girish, Arya Pooja, Mahajan Vibhuti, Bhavikatti JayateerthORCID, Pawar Ketakee, Thorat Aishwarya, Shah Priyanki, Goud Ramakrishna B., Roy BishnudeoORCID, Rajukutty Shon, Immanuel Sushil, Agarwal Dhiraj, Saha Sankhanil, Shivaraj Akshatha, Panikulam Patricia, Shome Rajeshwari, Gulzar Shah-E-Jahan, Sharma Anusmrithi U., Naik Ajinkya, Talashi ShrutiORCID, Belekar Madhuri, Yadav Ritu, Khude Poornima, V Mamatha, Shivalingaiah Sudarshan, Deshmukh UrmilaORCID, Bhise Chinmayee, Joshi Manjiri, Inbaraj Leeberk Raja, Chandrasingh SindhulinaORCID, Ghose AurnabORCID, Jamora Colin, Karumbati Anandi S., Sundaramurthy Varadharajan, Johnson Avita, Ramesh Naveen, Chetan Nirutha, Parthiban Chaitra, Ahmed Asma, Rakshit Srabanti, Adiga Vasista, D'souza George, Rale Vinay, George Carolin Elizabeth, John Jacob, Kawade AnandORCID, Chaturvedi Akanksha, Raghunathan Anu, Dias Mary, Bhosale Anand, Raghu Padinjat, Shashidhara L.S., Vyakarnam Annapurna, Bal Vineeta, Kang GagandeepORCID, Mayor SatyajitORCID
Funder
India Department of Atomic Energy
|
|